Overexpression of Gsα compensates for myocyte loss in diabetic cardiomyopathy

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 3, 2008, Pages 122-130

  Malhotra, Ashwani ^a   Kang, Barinder P S ^a   Vashistha, Himanshu ^a   Yadav, Virender S ^a   Meggs, Leonard G ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

adrenergic receptors; Diabetes mellitus; Gs overexpression; Hyperglycemia; Oxidative stress; Reactive oxygen species (ROS)

Indexed keywords

BETA ADRENERGIC RECEPTOR; CATALASE; DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; MALONALDEHYDE; PHOSPHOLAMBAN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN SUBUNIT; REACTIVE OXYGEN METABOLITE; SERINE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; APOPTOSIS REGULATORY PROTEIN; CALCIUM BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CHRONIC DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; DNA FRAGMENTATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC ENGINEERING; HEART HEMODYNAMICS; HEART LEFT VENTRICLE CONTRACTILITY; HEART MUSCLE CELL; HYPERGLYCEMIA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DOWN REGULATION; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEMODYNAMICS; IMMUNOBLOTTING; METABOLISM; METHODOLOGY; MONITORING; NICK END LABELING; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; TIME; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CALCIUM-BINDING PROTEINS; CARDIOMYOPATHIES; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HEMODYNAMICS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; MICE; MICE, TRANSGENIC; MONITORING, PHYSIOLOGIC; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, BETA; SERINE; STREPTOZOCIN; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 42149126053     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-015     Document Type: Article

References (33)

1. Asai, K., Yang, G.P., Geng, Y.J., Takagi, G., Bishop, S., Ishikawa, Y., et al. 1999. Beta-adrenergic receptor blockade arrests myocyte damage, and preserves cardiac function in the transgenic Gs (alpha) mouse. J. Clin. Invest. 104: 551-558. PMID:10487769.
2. Atkins, F.L., Dowell, R.T., and Love, S. 1985. β-Adrenergic receptors, adenylate cyclase activity, and cardiac dysfunction in diabetic rat. J. Cardiovasc. Pharmacol. 7: 66-70. doi:10.1097/00005344-198501000-00011. PMID:2580153.
3. Baynes, J.W., and Thorpe, S.R. 1999. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes, 48: 1-9. doi:10.2337/diabetes.48.1.1. PMID:9892215.
4. Bell, D.S.H. 1995. Diabetic cardiomyopathy: a unique entity or a complication of coronary artery disease? Diabetes Care, 18: 708-714. doi:10.2337/diacare.18.5.708. PMID:8586013.
5. Chintapalli, J., Yang, S., Opawumi, D., Goyal, S.R., Shamsuddin, N., Malhotra, A., et al. 2007. Inhibition of wild-type p66ShcA in mesangial cells prevents glycooxidant-dependent FOXO3a regulation and promotes the survival phenotype. Am. J. Physiol. Renal Physiol. 292: F523-F530. doi:10.1152/ajprenal.00215.2006. PMID:17077388.
6. Chu, G., Lester, J.W., Young, K.B., Luo, W., Zhai, J., and Kranias, E.G. 2000. A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta -agonists. J. Biol. Chem. 275: 38938-38943. doi:10.1074/jbc.M004079200. PMID:10988285.
7. 3 adrenoreceptors in rat hearts. Diabetes, 50: 455-461. doi:10.2337/diabetes.50.2.455. PMID:11272160.
8. Frustaci, A., Kajstura, J., Chimenti, C., Jakoniuk, I., Leri, A., Maseri, A., et al. 2000. Myocardial cell death in human diabetes. Circ. Res. 87: 1123-1132. PMID:11110769.
9. Gando, S. 1994. Pharmacological studies on alterations in myocardial beta-adrenoceptors and their intracellular signal transduction in experimental diabetic rats. Hokkaido Igaku Zasshi, 69: 1140-1153. PMID:7868054.
10. Gando, S., Hattori, Y., Akaishi, Y., Nishihira, J., and Kanno, M. 1997. Impaired contractile response to beta AR stimulation in diabetic rat hearts: alternations in beta ARs-G protein-adenylate cyclase system and phospholamban phosphorylation. J. Pharmacol. Exp. Ther. 282: 475-484. PMID:9223590.
11. Hardt, S.E., Geng, Y.J., Montagne, O., Asai, K., Hong, C., Yang, G.P., et al. 2002. Accelerated cardiomyopathy in mice with overexpression of cardiac G(s)alpha and a missense mutation in the alpha-myosin heavy chain. Circulation, 105: 614-620. doi:10.1161/hc0502.103012. PMID:11827928.
12. Hayat, S.A., Patel, B., Khattar, R.S., and Malik, R.A. 2004. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin. Sci. (Lond.), 107: 539-557. PMID:15341511.
13. Hockenbery, D.M. 1992. The bcl-2 oncogene and apoptosis. Semin. Immunol. 4: 413-420. PMID:1286168.
14. Homcy, C.J., Vatner, S.F., and Vatner, D.E. 1991. Beta-adrenergic receptor regulation in the heart in pathophysiologic states: abnormal adrenergic responsiveness in cardiac disease. Annu. Rev. Physiol. 53: 137-159. doi:10.1146/annurev.ph.53.030191.001033. PMID:1645945.
15. Hsueh, W., Abel, E.D., Breslow, J.L., Maeda, N., Davis, R.C., Fisher, E.A., et al. 2007. Recipes for creating animal models of diabetic cardiovascular disease. Circ. Res. 100: 1415-1427. doi:10.1161/01.RES.0000266449.37396. 1f. PMID:17525381.
16. Iwase, M., Bishop, S.P., Uechi, M., Vatner, D.E., Shannon, R.P., Kudej, R.K., et al. 1996. Adverse effects of chronic endogenous sympathetic drive induced by cardiac Gs overexpression. Circ. Res. 78: 517-524. PMID:8635208.
17. Iwase, M., Uechi, M., Vatner, D.E., Asia, K., Shannon, R.P., Kudej, R.K., et al. 1997. Cardiomyopathy induced by cardiac Gs overexpression. Am. J. Physiol. 272: H585-H589. PMID:9038982.
18. Kannel, W.B., and McGee, D.L. 1979. Diabetes and cardiovascular disease. The Framingham Heart Study. JAMA, 241: 2035-2038. doi:10.1001/jama.241. 19.2035. PMID:430798.
19. Kim, S.J., Yatani, A., Vatner, D.E., Yamamoto, S., Ishikawa, Y., Wagner, T.E., et al. 1999. Differential regulation of inotropy and lusitropy in overexpressed Gsalpha myocytes through cAMP and Ca2+ channel pathways. J. Clin. Invest. 103: 1089-1097. doi:10.1172/JCI4848. PMID:10194482.
20. Latifpour, J., and McNeill, J.H. 1984. Cardiac autonomic receptors: effect of long-term experimental diabetes. J. Pharmacol. Exp. Ther. 230: 242-249. PMID:6086879.
21. Malhotra, A., Begley, R., Kang, B.P., Rana, I., Liu, J., Yang, G., et al. 2005. PKC- {epsilon}-dependent survival signals in diabetic hearts. Am. J. Physiol. Heart Circ. Physiol. 289: H1343-H1350. doi:10.1152/ajpheart. 01200.2004. PMID:15894568.
22. Nishio, Y., Kashiwagi, A., Kida, Y., Kodama, M., Abe, N., Saeki, Y., and Shigeta, Y. 1988. Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic rats. Diabetes, 37: 1181-1187. doi:10.2337/diabetes.37.9.1181. PMID:2842211.
23. Richter, C. 1993. Pro-oxidants and mitochondrial Ca2+: their relationship to apoptosis and oncogenesis. FEBS Lett. 325: 104-107. doi:10.1016/0014-5793(93)81423-W.
24. Rodrigues, B., and McNeill, J.H. 1992. The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc. Res. 26: 913-922. PMID:1486584.
25. Rota, M., LeCapitaine, N., Hosoda, T., Boni, A., De Angelis, A., Padin-Iruegas, M.E., et al. 2006. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ. Res. 99: 42-52. doi:10.1161/01.RES.0000231289.63468.08. PMID:16763167.
26. Savarese, J.J., and Berkowitz, B.A. 1979. β-adrenergic receptor decrease in diabetic rat hearts. Life Sci. 25: 2075-2078. doi:10.1016/0024-3205(79)90200-5. PMID:231718.
27. Schmeichel, A.M., Schmelzer, J.D., and Low, P.A. 2003. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes, 52: 165-171. doi:10.2337/diabetes.52.1.165. PMID:12502508.
28. Sundaresan, P.R., Sharma, V.K., Gingold, S.L., and Banerjee, P.S. 1984. Decreased beta-adrenergic receptors in rat heart in streptozotocin-induced diabetes: role of thyroid hormones. Endocrinology, 114: 1358-1363. PMID:6323144.
29. Susztak, K., Raff, A.C., Schiffer, M., and Bottinger, E.P. 2006. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes, 55: 225-233. doi:10.2337/diabetes.55.01.06.db05-0894. PMID:16380497.
30. Takimoto, E., Champion, H.C., Li, M., Ren, S., Rodriguez, E.R., Tavazzi, B., et al. 2005. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J. Clin. Invest. 115: 1221-1231. doi:10.1172/JCI200521968. PMID:15841206.
31. Timmer, J.R., Ottervanger, J.P., de Boer, M.J., Boersma, E., Grines, C.L., Westerhout, C.M., et al. 2007. For the Primary Coronary Angioplasty vs. Thrombolysis-2 Trialists Collaborators Group. Primary Percutaneous Coronary Intervention Compared With Fibrinolysis for Myocardial Infarction in Diabetes Mellitus: Results From the Primary Coronary Angioplasty vs. Thrombolysis-2 Trial. Arch. Intern. Med. 167: 1353-1359. doi:10.1001/archinte.167.13. 1353. PMID:17620527.
32. Veis, D.J., Sorenson, C.M., Shutter, J.R., and Korsmeyer, S.J. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell, 75: 229-240. doi:10.1016/0092- 8674(93)80065-M. PMID:8402909.
33. Wallenstein, S., Zucker, C.L., and Fleiss, J.L. 1980. Some statistical methods useful in circulation research. Circ. Res. 47: 1-9. PMID:7379260.